Logo for Equillium Inc

Equillium Investor Relations Material

Latest events

Logo for Equillium Inc

R&D Day 2023

Logo for Equillium

Corporate Presentation

1 Apr, 2024
Logo for Equillium

Q4 2023

25 Mar, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Equillium Inc

Access all reports
Equillium Inc. is a clinical-stage biotechnology company that focuses on developing therapeutics for severe autoimmune and inflammatory disorders that have high unmet medical needs. It leverages a deep understanding of immunobiology to create novel treatments. Equillium's pipeline includes innovative, first-in-class immunomodulatory assets targeting critical immuno-inflammatory pathways. It is headquartered in La Jolla, California, and its shares are listed on the Nasdaq.